SCHEMBL596902

SCHEMBL596902

O=NI

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31318612 0.61
SCHEMBL809291 0.55
SCHEMBL168279 0.55
Nitrous Acid SCHEMBL10526485 0.50
SCHEMBL167239 0.50
SCHEMBL6727427 0.50
SCHEMBL3084255 0.50
SCHEMBL233303 0.50
SCHEMBL12461062 0.50
SCHEMBL22807002 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118451072-A Biphenyl tetrazole compound and preparation method thereof 浙江华海药业股份有限公司 2024-08-06 CN claimed
CN-117523663-A Method for re-identifying clothing changing pedestrian based on foreground image and noise clothing changing image guidance 西安电子科技大学 2024-02-06 CN claimed
WO-2023109731-A1 BIPHENYLTETRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR 浙江华海药业股份有限公司 2023-06-22 WO claimed
US-20150246931-A1 PROCESS FOR THE PREPARATION OF TAZOBACTAM HOSPIRA, INC. (US) 2015-09-03 US claimed
EP-2892903-A1 PROCESS FOR THE PREPARATION OF TAZOBACTAM Orchid Chemicals and Pharmaceuticals Ltd (IN) 2015-07-15 EP claimed
WO-2014037893-A1 PROCESS FOR THE PREPARATION OF TAZOBACTAM ORCHID CHEMICALS & PHARMACEUTICALS LTD (IN) 2014-03-13 WO claimed
US-20050096472-A1 Process for producing 3-unsubstituted 5-amino-4-nitrosopyrazole compound, and 2-hydroxyimino-3-oxopropionitrile, 3-hydrazono-2-hydroxyiminopropionitrile compound, and processes for producing these UBE INDUSTRIES, LTD. (JP) 2005-05-05 US claimed
EP-1475369-A1 PROCESS FOR PRODUCING 3-UNSUBSTITUTED 5-AMINO-4-NITROSOPYRAZOLE COMPOUND, AND 2-HYDROXYIMINO-3-OXOPROPIONITRILE, 3-HYDRAZONO-2-HYDROXYIMINOPROPIONITRILE COMPOUND, AND PROCESSES FOR PRODUCING THESE Ube Industries, Ltd. (JP) 2004-11-10 EP claimed
CN-120005889-A ShRNA for targeted inhibition of MZF1 gene expression and application thereof 中国人民解放军东部战区总医院 2025-05-16 CN disclosed
CN-118451072-A Biphenyl tetrazole compound and preparation method thereof 浙江华海药业股份有限公司 2024-08-06 CN disclosed
CN-117523663-A Method for re-identifying clothing changing pedestrian based on foreground image and noise clothing changing image guidance 西安电子科技大学 2024-02-06 CN disclosed
WO-2023109731-A1 BIPHENYLTETRAZOLE COMPOUND AND PREPARATION METHOD THEREFOR 浙江华海药业股份有限公司 2023-06-22 WO disclosed
CN-109384754-B Preparation method of dronedarone hydrochloride 新发药业有限公司 2020-06-09 CN disclosed
US-9944675-B2 Methods for preparing high throughput peptidomimetics, orally bioavailable drugs and compositions containing same UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2018-04-17 US disclosed
EP-1475369-A1 PROCESS FOR PRODUCING 3-UNSUBSTITUTED 5-AMINO-4-NITROSOPYRAZOLE COMPOUND, AND 2-HYDROXYIMINO-3-OXOPROPIONITRILE, 3-HYDRAZONO-2-HYDROXYIMINOPROPIONITRILE COMPOUND, AND PROCESSES FOR PRODUCING THESE Ube Industries, Ltd. (JP) 2004-11-10 EP disclosed
US-20040116732-A1 3,3-Dialkoxy-2-hydroxyiminopropionitriles, process for preparation thereof and process of preparing 5-amino-4-nitrosopyrazoles or salts thereof by the use of the same UBE INDUSTRIES, LTD. (JP) 2004-06-17 US disclosed
EP-1408025-A1 3,3-DIALKOXY-2-HYDROXYIMINOPROPIONITRILES, PROCESS FOR PREPARATION THEREOF AND PROCESS OF PREPARING 5-AMINO -4-NITROSOPYRAZOLES OR SALTS THEREOF BY THE USE OF THE SAME Ube Industries, Ltd. (JP) 2004-04-14 EP disclosed
US-5877185-A THERAPY FOR CANCER OR RETROVIRUS OCTAMER, INC. (US) 1999-03-02 US disclosed
WO-1996022791-A9 NOVEL SYNERGISTIC COMPOSITIONS USEFUL AS ANTI-TUMOR OR ANTI-RETROVIRAL AGENTS 1996-10-03 WO disclosed
WO-1996022791-A1 NOVEL SYNERGISTIC COMPOSITIONS USEFUL AS ANTI-TUMOR OR ANTI-RETROVIRAL AGENTS OCTAMER, INC. (US) 1996-08-01 WO disclosed